{"filing":{"accession":"0001298711-26-000009","url":"/filing/0001298711-26-000009","form_type":"4","issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_name_source":null,"issuer_ticker":"KRYS","issuer_url":"/issuer/0001711279","period_of_report":"2026-09-04","filed_date":"2026-09-04","acceptance_dt":"2026-09-04T19:15:49+00:00","acceptance_label":"2026-09-04 19:15 UTC","ingested_at":"2026-09-05T05:24:49.724574+00:00","ingested_label":"2026-09-05 05:24 UTC","schema_version":null,"source":"Layline","parse_status":"parsed","parse_ok":true,"edgar_url":"https://www.sec.gov/Archives/edgar/data/1711279/0001298711-26-000009-index.htm","day_url":"/filings/2026-09-04"},"owners":[{"owner_cik":"0001298711","owner_name":"Krishnan Suma","url":"/insider/0001298711","anchor":"owner-0001298711","role":"Director, Officer (President, R&D), Ten percent owner","officer_title":"President, R&D","is_director":true,"is_officer":true,"is_ten_percent":true,"is_other":false,"filing_anchor":"/filing/0001298711-26-000009#owner-0001298711"}],"line_owners":[{"owner_name":"Krishnan Suma","role":"Director, Officer (President, R&D), Ten percent owner"}],"transactions":[{"id":9305575,"accession":"0001298711-26-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001298711-26-000009","line_url":"/filing/0001298711-26-000009#line-1","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001298711","owner_name":"Krishnan Suma","owner_display_name":"Krishnan Suma","owner_url":"/insider/0001298711","role":"Director, Officer (President, R&D), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":520.0,"shares_display":"520","price_per_share":354.54,"price_display":"354.54","price_state":"stated","total_value":184360.8,"total_display":"184,360.80","total_whole":"184,361","shares_owned_after":1326625.0,"shares_owned_after_display":"1,326,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-09-04","filed_date":"2026-09-04","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9305574,"accession":"0001298711-26-000009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001298711-26-000009","line_url":"/filing/0001298711-26-000009#line-2","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001298711","owner_name":"Krishnan Suma","owner_display_name":"Krishnan Suma","owner_url":"/insider/0001298711","role":"Director, Officer (President, R&D), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2006.0,"shares_display":"2,006","price_per_share":355.5719,"price_display":"355.57","price_state":"stated","total_value":713277.2314,"total_display":"713,277.23","total_whole":"713,277","shares_owned_after":1324619.0,"shares_owned_after_display":"1,324,619","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-09-04","filed_date":"2026-09-04","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9305573,"accession":"0001298711-26-000009","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001298711-26-000009","line_url":"/filing/0001298711-26-000009#line-3","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001298711","owner_name":"Krishnan Suma","owner_display_name":"Krishnan Suma","owner_url":"/insider/0001298711","role":"Director, Officer (President, R&D), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3267.0,"shares_display":"3,267","price_per_share":356.3679,"price_display":"356.37","price_state":"stated","total_value":1164253.9293,"total_display":"1,164,253.93","total_whole":"1,164,254","shares_owned_after":1321352.0,"shares_owned_after_display":"1,321,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-09-04","filed_date":"2026-09-04","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9305572,"accession":"0001298711-26-000009","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001298711-26-000009","line_url":"/filing/0001298711-26-000009#line-4","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001298711","owner_name":"Krishnan Suma","owner_display_name":"Krishnan Suma","owner_url":"/insider/0001298711","role":"Director, Officer (President, R&D), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3962.0,"shares_display":"3,962","price_per_share":357.5742,"price_display":"357.57","price_state":"stated","total_value":1416708.9804,"total_display":"1,416,708.98","total_whole":"1,416,709","shares_owned_after":1317390.0,"shares_owned_after_display":"1,317,390","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-09-04","filed_date":"2026-09-04","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9305571,"accession":"0001298711-26-000009","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001298711-26-000009","line_url":"/filing/0001298711-26-000009#line-5","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001298711","owner_name":"Krishnan Suma","owner_display_name":"Krishnan Suma","owner_url":"/insider/0001298711","role":"Director, Officer (President, R&D), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3180.0,"shares_display":"3,180","price_per_share":358.4203,"price_display":"358.42","price_state":"stated","total_value":1139776.554,"total_display":"1,139,776.55","total_whole":"1,139,777","shares_owned_after":1314210.0,"shares_owned_after_display":"1,314,210","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-09-04","filed_date":"2026-09-04","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9305570,"accession":"0001298711-26-000009","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001298711-26-000009","line_url":"/filing/0001298711-26-000009#line-6","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001298711","owner_name":"Krishnan Suma","owner_display_name":"Krishnan Suma","owner_url":"/insider/0001298711","role":"Director, Officer (President, R&D), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3392.0,"shares_display":"3,392","price_per_share":359.3862,"price_display":"359.39","price_state":"stated","total_value":1219037.9904,"total_display":"1,219,037.99","total_whole":"1,219,038","shares_owned_after":1310818.0,"shares_owned_after_display":"1,310,818","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-09-04","filed_date":"2026-09-04","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9305569,"accession":"0001298711-26-000009","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001298711-26-000009","line_url":"/filing/0001298711-26-000009#line-7","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001298711","owner_name":"Krishnan Suma","owner_display_name":"Krishnan Suma","owner_url":"/insider/0001298711","role":"Director, Officer (President, R&D), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2320.0,"shares_display":"2,320","price_per_share":360.466,"price_display":"360.47","price_state":"stated","total_value":836281.12,"total_display":"836,281.12","total_whole":"836,281","shares_owned_after":1308498.0,"shares_owned_after_display":"1,308,498","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-09-04","filed_date":"2026-09-04","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9305568,"accession":"0001298711-26-000009","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001298711-26-000009","line_url":"/filing/0001298711-26-000009#line-8","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001298711","owner_name":"Krishnan Suma","owner_display_name":"Krishnan Suma","owner_url":"/insider/0001298711","role":"Director, Officer (President, R&D), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1242.0,"shares_display":"1,242","price_per_share":361.61,"price_display":"361.61","price_state":"stated","total_value":449119.62,"total_display":"449,119.62","total_whole":"449,120","shares_owned_after":1307256.0,"shares_owned_after_display":"1,307,256","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-09-04","filed_date":"2026-09-04","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9305567,"accession":"0001298711-26-000009","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001298711-26-000009","line_url":"/filing/0001298711-26-000009#line-9","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001298711","owner_name":"Krishnan Suma","owner_display_name":"Krishnan Suma","owner_url":"/insider/0001298711","role":"Director, Officer (President, R&D), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1992.0,"shares_display":"1,992","price_per_share":362.6527,"price_display":"362.65","price_state":"stated","total_value":722404.1784,"total_display":"722,404.18","total_whole":"722,404","shares_owned_after":1305264.0,"shares_owned_after_display":"1,305,264","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-09-04","filed_date":"2026-09-04","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9305566,"accession":"0001298711-26-000009","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001298711-26-000009","line_url":"/filing/0001298711-26-000009#line-10","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001298711","owner_name":"Krishnan Suma","owner_display_name":"Krishnan Suma","owner_url":"/insider/0001298711","role":"Director, Officer (President, R&D), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":565.0,"shares_display":"565","price_per_share":363.3404,"price_display":"363.34","price_state":"stated","total_value":205287.326,"total_display":"205,287.33","total_whole":"205,287","shares_owned_after":1304699.0,"shares_owned_after_display":"1,304,699","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-09-04","filed_date":"2026-09-04","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9305565,"accession":"0001298711-26-000009","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001298711-26-000009","line_url":"/filing/0001298711-26-000009#line-11","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001298711","owner_name":"Krishnan Suma","owner_display_name":"Krishnan Suma","owner_url":"/insider/0001298711","role":"Director, Officer (President, R&D), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1329.0,"shares_display":"1,329","price_per_share":364.4771,"price_display":"364.48","price_state":"stated","total_value":484390.0659,"total_display":"484,390.07","total_whole":"484,390","shares_owned_after":1303370.0,"shares_owned_after_display":"1,303,370","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-09-04","filed_date":"2026-09-04","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9305564,"accession":"0001298711-26-000009","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001298711-26-000009","line_url":"/filing/0001298711-26-000009#line-12","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001298711","owner_name":"Krishnan Suma","owner_display_name":"Krishnan Suma","owner_url":"/insider/0001298711","role":"Director, Officer (President, R&D), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":826.0,"shares_display":"826","price_per_share":365.4139,"price_display":"365.41","price_state":"stated","total_value":301831.8814,"total_display":"301,831.88","total_whole":"301,832","shares_owned_after":1302544.0,"shares_owned_after_display":"1,302,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-09-04","filed_date":"2026-09-04","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9305563,"accession":"0001298711-26-000009","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001298711-26-000009","line_url":"/filing/0001298711-26-000009#line-13","is_derivative":false,"issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001711279","owner_cik":"0001298711","owner_name":"Krishnan Suma","owner_display_name":"Krishnan Suma","owner_url":"/insider/0001298711","role":"Director, Officer (President, R&D), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":399.0,"shares_display":"399","price_per_share":366.556,"price_display":"366.56","price_state":"stated","total_value":146255.844,"total_display":"146,255.84","total_whole":"146,256","shares_owned_after":1302145.0,"shares_owned_after_display":"1,302,145","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-09-04","filed_date":"2026-09-04","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null}],"n_transactions":13,"line_constants":{"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true},"provenance":{"source_pass":"Layline","parse_status":"parsed","schema_version":null,"retrieved_at":"2026-09-05T05:24:49.724574+00:00","retrieved_label":"2026-09-05 05:24 UTC","primary_document":"https://www.sec.gov/Archives/edgar/data/1711279/0001298711-26-000009-index.htm","accepted_at":"2026-09-04T19:15:49+00:00","accepted_label":"2026-09-04 19:15 UTC"},"related":[{"accession":"0001298709-26-000011","url":"/filing/0001298709-26-000011","form_type":"4","issuer_cik":"0001711279","issuer_name":"Krystal Biotech, Inc.","issuer_name_source":null,"issuer_ticker":"KRYS","issuer_url":"/issuer/0001711279","period_of_report":"2026-09-04","filed_date":"2026-09-04","acceptance_dt":"2026-09-04T19:14:09+00:00","acceptance_label":"2026-09-04 19:14 UTC","ingested_at":"2026-09-05T05:24:49.724574+00:00","ingested_label":"2026-09-05 05:24 UTC","schema_version":null,"source":"Layline","parse_status":"parsed","parse_ok":true,"edgar_url":"https://www.sec.gov/Archives/edgar/data/1711279/0001298709-26-000011-index.htm","day_url":"/filings/2026-09-04"}],"related_rule":"Other filings held for the same issuer and the same period of report. This is a heuristic match, not an authoritative amendment link: the store holds no 4/A-to-original relation and the catalog does not invent one.","canonical_url":"https://ebomi.com/filing/0001298711-26-000009","retrieved_at":"2026-09-05T11:28:34+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-09-04","last_ingest":"2026-09-05T05:24:49.724574+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}